2023-05-02 13:07:54 ET
- Neurocrine Biosciences ( NASDAQ: NBIX ) is scheduled to announce Q1 earnings results on Wednesday, May 3rd, before market open.
- The consensus EPS Estimate is $0.74 (+146.7% Y/Y) and the consensus Revenue Estimate is $409.07M (+31.7% Y/Y).
- Over the last 2 years, NBIX has beaten EPS estimates 0% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 12 downward. Revenue estimates have seen 9 upward revisions and 5 downward.
For further details see:
Neurocrine Biosciences Q1 2023 Earnings Preview